Now showing items 1-1 of 1

    • Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report 

      Borisov, S; Danila, E; Maryandyshev, A; Dalcolmo, M; Miliauskas, S; Kuksa, L; Manga, S; Skrahina, A; Diktanas, S; Codecasa, LR (European Respiratory Society, 2019-12-19)
      WHO (World Health Organization) recommends countries to implement pharmacovigilance and to collect information on aDSM (active drug safety monitoring and management of adverse events-AEs). Aim of this prospective study ...